William Ure Primrose
Direktor/Vorstandsmitglied bei Gyreox Ltd.
Profil
William Ure Primrose was the founder of PanTherix Ltd.
(1997) and CYP Design Ltd.
(2012), where he held the title of Chief Executive Officer.
Currently, he is a Director at Gyreox Ltd.
(2019 - present).
Previously, he held the position of Chief Executive Officer at Theryte Ltd.
and IntelliHep Ltd.
Dr. Primrose obtained a doctorate degree from The University of Edinburgh.
Aktive Positionen von William Ure Primrose
Unternehmen | Position | Beginn |
---|---|---|
Gyreox Ltd.
Gyreox Ltd. Miscellaneous Commercial ServicesCommercial Services Gyreox Ltd. engages in research and experimental development on biotechnology. The company was founded on May 20, 2019 and is headquartered in Oxford, the United Kingdom. | Direktor/Vorstandsmitglied | 20.05.2019 |
Ehemalige bekannte Positionen von William Ure Primrose
Unternehmen | Position | Ende |
---|---|---|
CYP Design Ltd.
CYP Design Ltd. BiotechnologyHealth Technology CYP Design Ltd. provides drug research and development services. It engages in the supporting drug research and development needs by offering stabilized, highly active cytochrome P450 (CYP) enzyme products. The firm also offers reliable contract research services in metabolism and toxicity testing and in bio catalysis. It has developed a generic expression system for the production of recombinant cytochrome P450 (CYP) in yeast, insect and mammalian cells. The company was founded by Bhabatosh Chaudhuri, Paul Barton Rodgers and William Primose in 2012 and is headquartered in Leicester, the United Kingdom. | Vorstandsvorsitzender | - |
PanTherix Ltd.
PanTherix Ltd. Pharmaceuticals: GenericHealth Technology PanTherix Ltd. is a privately held anti-infectives company using structure-based drug design to discover and develop new antibiotics acting on novel targets. The company integrates structural and functional information obtained by protein crystallography and enzymology to accelerate the gene to drug process. The company was founded in 1997 and is headquartered in Glasgow, the United Kingdom. | Gründer | - |
IntelliHep Ltd. | Vorstandsvorsitzender | - |
Theryte Ltd.
Theryte Ltd. Pharmaceuticals: MajorHealth Technology Theryte Ltd. operated as a drug discovery and development company that is committed to bringing new cancer treatments to market. It also operated a virtual model for its discovery and development operations, outsourcing its chemistry, discovery biology and in vivo testing to a number of specialist commercial providers in Europe and North America. The company was founded by Hilmar Meek Warenius, Guenter Herbert Schmidt, Robert John Bishop and Robert Alexander Walker Johnstone on November 20, 1997 and headquartered in Keynsham, the United Kingdom. | Vorstandsvorsitzender | - |
Ausbildung von William Ure Primrose
The University of Edinburgh | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Theryte Ltd.
Theryte Ltd. Pharmaceuticals: MajorHealth Technology Theryte Ltd. operated as a drug discovery and development company that is committed to bringing new cancer treatments to market. It also operated a virtual model for its discovery and development operations, outsourcing its chemistry, discovery biology and in vivo testing to a number of specialist commercial providers in Europe and North America. The company was founded by Hilmar Meek Warenius, Guenter Herbert Schmidt, Robert John Bishop and Robert Alexander Walker Johnstone on November 20, 1997 and headquartered in Keynsham, the United Kingdom. | Health Technology |
PanTherix Ltd.
PanTherix Ltd. Pharmaceuticals: GenericHealth Technology PanTherix Ltd. is a privately held anti-infectives company using structure-based drug design to discover and develop new antibiotics acting on novel targets. The company integrates structural and functional information obtained by protein crystallography and enzymology to accelerate the gene to drug process. The company was founded in 1997 and is headquartered in Glasgow, the United Kingdom. | Health Technology |
IntelliHep Ltd. | |
CYP Design Ltd.
CYP Design Ltd. BiotechnologyHealth Technology CYP Design Ltd. provides drug research and development services. It engages in the supporting drug research and development needs by offering stabilized, highly active cytochrome P450 (CYP) enzyme products. The firm also offers reliable contract research services in metabolism and toxicity testing and in bio catalysis. It has developed a generic expression system for the production of recombinant cytochrome P450 (CYP) in yeast, insect and mammalian cells. The company was founded by Bhabatosh Chaudhuri, Paul Barton Rodgers and William Primose in 2012 and is headquartered in Leicester, the United Kingdom. | Health Technology |
Gyreox Ltd.
Gyreox Ltd. Miscellaneous Commercial ServicesCommercial Services Gyreox Ltd. engages in research and experimental development on biotechnology. The company was founded on May 20, 2019 and is headquartered in Oxford, the United Kingdom. | Commercial Services |